Search
for
Sort by
Research 571–600 of 1000+
- Adverse health effects of androgen use
- Genetic ablation of myelin protein zero-like 3 in mice increases energy expenditure, improves glycemic control, and reduces hepatic lipid synthesis
- NAD⁺ Biology in Ageing and Chronic Disease: Mechanisms and Evidence across Skin, Fertility, Osteoarthritis, Hearing and Vision Loss, Gut Health, Cardiovascular–Hepatic Metabolism, Neurological Disorders, and Muscle
- Features of steroidogenesis and arterial hypertension in men in different types of "physiological" male hyperandrogenism
- 46,XY DSD due to impaired androgen production
- Polycystic Ovary Syndrome in the Context of Pituitary Adenomas: Prevalence, Pathophysiology and Clinical Management
- Multiple Autoimmune Syndrome type 3- Thyroiditis, Vitiligo and Alopecia Areata
- Ovarian steroid cell tumor (not otherwise specified) with subsequent spontaneous pregnancy after tumor removal: a case report and literature review
- Hypoparathyroidism as the single major component for decades of autoimmune polyglandular syndrome type 1
- Influence of external factors on hair cortisol concentrations
- Male reproductive health after 3 months from SARS-CoV-2 infection: a multicentric study
- Treatment of Nonclassic 11-Hydroxylase Deficiency with Ashwagandha Root
- Aldosterone- and cortisol-cosecreting adrenal adenoma, ovarian hyperthecosis and breast cancer
- Endocrine abnormalities in ring chromosome 11: a case report and review of the literature
- Efficacy of topical minoxidil in enhancing beard growth in a group of transgender assigned female at birth individuals on gender affirming hormone therapy
- Hairless Suppresses Vitamin D Receptor Transactivation in Human Keratinocytes
- THE EFFECT OF SPIRONOLACTONE ON HIRSUTISM AND FEMALE ANDROGEN METABOLISM
- Elevated Dehydroepiandrosterone Sulfate Levels as the Reproductive Phenotype in the Brothers of Women with Polycystic Ovary Syndrome
- A Humanized Mouse Model of Hereditary 1,25-Dihydroxyvitamin D–Resistant Rickets Without Alopecia
- National consensus on the management of patients with hyperandrogenism (2016)
- Hyperandrogenism and menstrual imbalance are the best predictors of metformin response in PCOS patients
- A Model for Predicting Polycystic Ovary Syndrome Using Serum AMH, Menstrual Cycle Length, Body Mass Index and Serum Androstenedione in Chinese Reproductive Aged Population: A Retrospective Cohort Study
- Nuclear and cytosol Androgen Receptor in Androgen Dependent Dermatoses in Female Patients
- Modern approaches to diagnostics of hyperandrogenism distributed forms in reproductive aged women
- Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women
- Diagnostic imaging in congenital adrenal hyperplasia – how does it help?
- Thyroid Disease in Alopecia Areata, Lichen Planopilaris, and Frontal Fibrosing Alopecia—A Case Control Study of 144 Patients
- An adolescent girl with coexisting ovarian mature cystic teratoma and HAIR-AN syndrome, an extreme subtype of polycystic ovarian syndrome
- Gender-Affirming Hormonal Treatment in Transgender People Assigned Female at Birth (AFAB)
- Polycystic ovary syndrome: pragmatic management across levels of care